TNFAIP3 ameliorates the degeneration of inflammatory human nucleus pulposus cells by inhibiting mTOR signaling and promoting autophagy

Aging (Albany NY). 2020 Nov 20;12(23):24242-24254. doi: 10.18632/aging.104160. Epub 2020 Nov 20.

Abstract

Autophagy is involved in degenerative diseases such as osteoarthritis and disc degeneration. Although, tumor necrosis factor α-induced protein 3 (TNFAIP3) is well-known as a key regulator of inflammation and autophagy, it is still not clear whether TNFAIP3 regulates autophagy to protect from human disc cells degeneration. We hypothesize that TNFAIP3 may also regulate autophagy to inhibit pro-inflammatory cytokines expression in human nucleus pulposus cells (NPCs). In this study, TNFAIP3 expression was increased in degenerative disc tissue as well as LPS-stimulated human NPCs, and the effect of TNFAIP3 in LPS-induced NPCs was further explored. The results demonstrated that pro-inflammatory cytokines expression in TNFAIP3-His cells was decreased, while it was increased in TNFAIP3-siRNA cells. Further molecular mechanism research showed that TNFAIP3-siRNA cells enhanced the phosphorylation of mammalian target of rapamycin (mTOR) and inhibited autophagy. Meanwhile, after treatment of TNFAIP3-siRNA cells with the mTOR inhibitor Torin1, the level of autophagy increased and the decrease of extracellular matrix was reversed. In summary, overexpressed TNFAIP3 can promote autophagy and reduce inflammation in LPS-induced human NPCs. Moreover, autophagy triggered by TNFAIP3 can ameliorate the degeneration of inflammatory human NPCs, providing a potential and an attractive therapeutic strategy for degenerative disease.

Keywords: TNFAIP3; extracellular matrix; human nucleus pulposus cells; inflammation; mTOR signaling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autophagy* / drug effects
  • Case-Control Studies
  • Cells, Cultured
  • Cytokines / metabolism*
  • Extracellular Matrix / metabolism
  • Extracellular Matrix / pathology
  • Humans
  • Inflammation / genetics
  • Inflammation / metabolism*
  • Inflammation / pathology
  • Inflammation Mediators / metabolism*
  • Intervertebral Disc Degeneration / genetics
  • Intervertebral Disc Degeneration / metabolism*
  • Intervertebral Disc Degeneration / pathology
  • Lipopolysaccharides / toxicity
  • Nucleus Pulposus / drug effects
  • Nucleus Pulposus / metabolism*
  • Nucleus Pulposus / pathology
  • Phosphorylation
  • Signal Transduction
  • TOR Serine-Threonine Kinases / metabolism*
  • Tumor Necrosis Factor alpha-Induced Protein 3 / genetics
  • Tumor Necrosis Factor alpha-Induced Protein 3 / metabolism*

Substances

  • Cytokines
  • Inflammation Mediators
  • Lipopolysaccharides
  • MTOR protein, human
  • TOR Serine-Threonine Kinases
  • TNFAIP3 protein, human
  • Tumor Necrosis Factor alpha-Induced Protein 3